Our Top 10
Best Selling
Medicines
in 2012

For more information on any of these medicines, visit:
Pfizer Pharmaceutical Products

Lyrica
(pregabalin) $4,158 million
Lipitor
(atorvastatin) $3,948 million
Enbrel (Outside the U.S. and Canada)
(etanercept) $3,737 million
Prevnar 13/
Prevenar 13
(pneumococcal polysaccharide conjugate vaccine) $3,718 million
Celebrex
(celecoxib) $2,719 million
Viagra
(sildenafil) $2,051 million
Norvasc
(amlodipine besylate) $1,349 million
Zyvox
(linezolid) $1,345 million
Sutent
(sunitinib malate) $1,236 million
Premarin
Family
(conjugated estrogens) $1,073 million